![]() |
市场调查报告书
商品编码
1792268
2025 年至 2033 年生育服务市场报告(依不孕症原因、程序、服务、最终使用者和地区划分)Fertility Services Market Report by Cause of Infertility, Procedure, Service, End-User, and Region 2025-2033 |
2024年,全球生育服务市场规模达461亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到1,420亿美元,2025-2033年期间的复合年增长率(CAGR)为12.65%。推动市场发展的因素包括:不孕症病例数的增加、个人对各种生育治疗的认知度和接受度的提高,以及税收优惠等政府优惠措施。
政府的优惠倡议
为提高生育率,上海市于 2024 年 5 月 31 日将 12 种辅助生殖技术 (ART) 纳入基本医疗保险。这项措施减轻了不孕症夫妇昂贵的生育治疗负担。各国政府机构透过提供多种服务,使不孕症患者更容易取得且负担得起生育治疗。他们为体外受精 (IVF) 等生育治疗提供直接财政援助或补贴。这减少了患者的自付费用,从而增加了生育服务需求。他们还投资公立生育诊所,以比私人诊所更低的价格提供高品质的照护。这确保了更多人,无论其经济状况如何,都能获得生育服务。此外,管理部门正在建立法律框架,规范和支持生育治疗,确保其安全性、合乎道德且可近性。此外,在某些国家,与生育治疗相关的费用可以免税,从而允许个人减少应税收入并减轻这些服务的经济负担。
不孕不育病例不断增加
在全球范围内,不孕症病例的不断增加,为生育服务市场带来了良好的前景。由于生活方式的改变、环境影响、年龄相关问题以及疾病,人们面临这些问题。现代饮食缺乏重要的营养素,这可能对生殖健康有害。在当今快节奏的生活方式中,高压力普遍存在,这会导致月经週期紊乱和精子品质下降。除了导致糖尿病和高血压等生活方式障碍外,慢性压力也会导致不孕症问题。此外,越来越多的人出于各种原因选择推迟生育,包括职业抱负、经济稳定和个人目标,这为生育服务市场提供了洞察。此外,有助于治疗这些问题的治疗设备的需求也在增加。根据IMARC Group的研究报告,预计2032年,全球不孕症治疗设备市场规模将达到7.295亿美元。
提高对各种治疗方法的认识和接受度
人们对各种生育治疗的认知和接受度不断提高,推动了市场的成长。世界各地的管理机构和非政府机构正在组织各种活动,旨在提高人们对各种治疗方案的认识,从而促进生育服务的成长。这些活动通常利用媒体、社交平台和社区外展活动来传播有关不孕不育原因和早期介入益处的讯息。此外,一些名人坦诚谈论自己的不孕症问题以及使用试管受精、代孕或卵子冷冻等方法的案例也有助于减轻人们对这些治疗方案的偏见。这种曝光激励着其他人去探索类似的选择,而不必担心被他人评判。此外,市场上的主要公司正在与主要参与者建立合作伙伴关係,以扩展其服务范围并增加生育服务市场的收入。例如,2023年4月26日,提供弹性融资计画和礼宾支援服务的全国性家庭建设平台「未来家庭 (FF)」与北美顶级全包生殖服务提供者Prelude Network(R)达成独家协议。此次合作将扩大高端生育服务的财务可近性,并为患者提供更多财务选择,并使其能够正确理解治疗费用。 FF还开发了一个个人化支付选择工具,使患者能够根据个人治疗计划了解生育费用。
男性不孕症占据了大部分市场份额
男性不孕问题可能由多种因素造成,包括不良饮食和运动习惯。卵胞浆内单一精子注射 (ICSI) 等治疗方法正变得越来越普遍,尤其是在精子数量低或活力问题方面。目前有多种药物和荷尔蒙疗法可用于治疗男性不孕症的特定原因,例如荷尔蒙失衡或感染。这些治疗方法能够有效解决男性不孕问题。
体外受精与卵胞浆内单一精子注射(IVF with ICSI)占据业界最大份额
体外受精结合卵胞浆内单一精子注射(IVF-ICSI)对于严重男性不孕症患者非常有效,而传统的IVF方法可能效果不佳。这种方法可以最大限度地提高个体受精的几率。随着人们寻求辅助生殖技术(ART)来克服不孕症,对IVF-ICSI等有效治疗方法的需求日益增长,这为生育服务产业带来了良好的前景。
冷冻非捐赠器官占据主要市场份额
非捐赠冷冻服务是指使用来自预期母亲或父母的冷冻卵子或胚胎,无需捐赠者的参与。冷冻保存技术的进步很可能推动了人们对非捐赠冷冻服务的青睐,这种技术提高了成功率,并让患者在选择生育治疗时间方面更加灵活。玻璃化冷冻等卵子冷冻技术的进步提高了卵子在冷冻和解冻过程中的存活率。这使得冷冻卵子成为未来生育治疗更可行的选择,并展现了生育服务市场的动态。
生育诊所在市场上占据明显主导地位
生育诊所提供广泛的治疗方案,例如体外受精 (IVF)、卵胞浆内单一精子注射 (ICSI)、卵子和精子捐赠、生育力保存以及基因检测。它们能够提供一站式全方位服务,使其成为患者的首选。这些诊所通常会根据每位患者的特定需求提供个人化治疗方案,从而提高患者的满意度。生育服务市场凸显出,生育诊所正致力于扩大其覆盖范围,并在各个地区建立诊所网络,使更广泛的人群能够享受其服务。此外,这些诊所配备了生殖医学专家,包括生育专家、胚胎学家和遗传咨询师,以确保提供高品质的照护。它们还配备了最新的技术和实验室设施,这对于执行先进的程序至关重要。
亚太地区引领市场,占据最大的生育服务市场份额
该报告还对所有主要区域市场进行了全面分析,包括欧洲、北美、亚太地区、中东和非洲以及拉丁美洲。报告指出,亚太地区是生育服务最大的区域市场。
亚太地区汇聚了中国、印度等全球人口最多的国家。由于人口众多,面临不孕症问题的人数众多,这推动了对生育服务的需求。城市化、生活方式的改变、结婚年龄的延迟以及首次生育年龄的提高,导致该地区不孕率上升。此外,生育服务业报告显示,污染和毒素暴露等环境因素起着至关重要的作用。此外,该地区的管理部门正在鼓励与不孕症相关的治疗方案。例如,2024年,马哈拉施特拉邦政府机构在一些选定的公立医学院和医院(GMCH)设立了体外受精(IVF)中心,为数千对不孕夫妇提供免费治疗。此举是为了应对马哈拉施特拉邦总生育率(TFR)的惊人下降。
(请注意,这只是关键参与者的部分列表,完整列表在报告中提供。)
The global fertility services market size reached USD 46.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 142.0 Billion by 2033, exhibiting a growth rate (CAGR) of 12.65% during 2025-2033. There are several factors that are driving the market, which include rising number of infertility cases, increasing awareness and acceptance among individuals about a variety of fertility treatments, and favorable government initiatives like tax benefits.
Favorable Government Initiatives
In an effort to increase the birth rate, Shanghai integrated 12 forms of assisted reproductive technology (ART) into basic health insurance on May 31, 2024. This initiative reduced infertile couples' burden from expensive fertility treatments. Government agencies of various countries are making fertility treatments more accessible and affordable for individuals facing infertility issues by providing numerous services. They are providing direct financial assistance or subsidies for fertility treatments such as in vitro fertilization (IVF). This reduces the out-of-pocket costs for patients, thereby increasing fertility services demand. They are also investing in public fertility clinics to provide high-quality care at lower costs as compared to private clinics. This ensures that a wider range of people, regardless of their financial status, can access fertility services. In addition, governing authorities are establishing legal frameworks that regulate and support fertility treatments and ensuring that they are safe, ethical, and accessible. Furthermore, in some countries, the costs associated with fertility treatments may be tax-deductible, allowing individuals to reduce their taxable income and lessen the financial burden of these services.
Increasing Number of Infertility Cases
The growing number of infertility cases among the masses across the globe is offering a favorable fertility services market outlook. Individuals are dealing with these problems as a result of changing lifestyles, environmental influences, age-related problems, and medical ailments. Modern diets are deficient in vital nutrients, which can be harmful to reproductive health. In today's fast-paced lifestyle, high levels of stress are prevalent and can cause menstrual cycle disruption and sperm quality reduction. In addition to causing lifestyle disorders like diabetes and hypertension, chronic stress also causes infertility issues. Apart from this, the rising number of people are choosing to delay parenthood for various reasons including career aspirations, financial stability, and personal goals, which provide fertility services market insights. Furthermore, there is an increase in the demand for treatment devices that are beneficial in treating these issues among individuals. As per the research report of the IMARC Group, the global infertility treatment devices market is expected to reach US$ 729.5 Million by 2032.
Rising Awareness and Acceptance About a Variety of Treatment
The increasing awareness and acceptance of various fertility treatments among individuals is propelling the market growth. Governing agencies and non-governmental agencies around the world are organizing campaigns that benefit in generating awareness among individuals about the wide availability of treatment options available, which is bolstering the fertility services growth. These campaigns often use media, social platforms, and community outreach to disseminate information about the causes of infertility and the benefits of early intervention. Besides this, publicized instances involving celebrities who candidly talk about their infertility issues and usage of IVF, surrogacy, or egg freezing help to lessen the stigma attached to these procedures. Its visibility inspires others to investigate comparable choices without worrying about being judged by others. Furthermore, major companies in the market are engaging in partnerships and collaborations among major players to expand their services and increase fertility services market revenue. For instance, on 26 April 2023, a nationwide platform for family-building with flexible financing plans and concierge support services 'Future Family (FF)' and Prelude Network(R), a top provider of all-inclusive reproductive services in North America, established an exclusive agreement. The partnership will expand financial accessibility to premium fertility services and empower patients with more financial options and a proper understanding of treatment costs. FF also developed a personalized payment choice tool that allows patients to understand fertility costs based on their individual treatment plans.
Male infertility accounts for the majority of the market share
Male infertility issues can result from a number of factors including bad eating and poor exercise habits. Treatments like intracytoplasmic sperm injection (ICSI), in which a single sperm is injected straight into an egg, are becoming common, especially when it comes to low sperm counts or motility problems. Several medications and hormonal therapies are available to address specific causes of male infertility like hormonal imbalances or infections. These treatments are effective in providing a viable solution to male infertility.
In vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI) holds the largest share of the industry
In vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI) is beneficial in cases of severe male infertility, where traditional IVF methods might not be as effective. It is used to maximize the chances of fertilization among individuals. The growing demand for effective treatments like IVF with ICSI, as people are seeking assisted reproductive technologies (ART) to overcome infertility, is offering a favorable fertility services industry outlook.
Frozen non-donor represents the leading market segment
Frozen non-donor services include the use of frozen eggs or embryos from the intended mother or parents, without the involvement of donors. The preference for frozen non-donor services is likely driven by advancements in cryopreservation techniques, offering higher success rates and flexibility for patients in terms of timing their fertility treatments. Advancements in egg freezing techniques like vitrification are leading to higher survival rates of eggs during the freezing and thawing processes. This makes frozen eggs a more viable option for future fertility treatments and shows fertility services market dynamics.
Fertility clinics exhibit a clear dominance in the market
Fertility clinics offer a wide range of treatments like IVF, ICSI, egg and sperm donation, fertility preservation, and genetic testing. Their ability to provide a full spectrum of services under one roof makes them the go-to option for patients. These clinics often provide personalized treatment plans tailored to the specific needs of each patient, which increases the chances of patient satisfaction. Fertility services market highlights that fertility clinics are focusing on expanding their reach and establishing networks of clinics in various regions, making their services more accessible to a broader population. In addition, these clinics are staffed with experts in reproductive medicine including fertility specialists, embryologists, and genetic counselors, ensuring high-quality care. They are also equipped with the latest technology and lab facilities, which are crucial for performing advanced procedures.
Asia Pacific leads the market, accounting for the largest fertility services market share
The report has also provided a comprehensive analysis of all the major regional markets, which include Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, Asia Pacific represents the largest regional market for fertility services.
Asia Pacific is home to some of the world's most populous countries such as China and India. With a large population, the number of people facing infertility is significant, driving the demand for fertility services. Urbanization, changing lifestyles, delayed marriages, and increasing age of first-time parents are contributing to rising infertility rates among individuals in the region. Moreover, fertility services industry report demonstrates that environmental factors such as pollution and exposure to toxins, play a crucial role. Besides this, governing authorities in the region are encouraging treatment solutions related to infertility. For instance, in 2024, government agencies in Maharashtra launched in-vitro fertilization (IVF) centers in some selected government-run medical colleges and hospitals (GMCH) to provide free treatment to thousands of couples grappling with infertility. The move was made in response to the alarming drop in Maharashtra's total fertility rate (TFR).
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)